Company Description
Madrigal is developing novel, high-quality small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases. The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease and non-alcoholic steatohepatitis (NASH), diabetes, dyslipidemia and cardiovascular disease.
Company Info
COMPANY ADDRESS
200 Barr Harbor Drive
Suite 400
West Conshohocken, PA 19428
United States
COMPANY EMAIL
COMPANY WEBSITE
Latest Company News